Uncategorized

Replimune looks ahead as repeat CRL speeds the company’s decline

Published

5 hours ago

on

Replimune’s second complete response letter for its cancer therapy last week is already leading to multiple rounds of layoffs and existential questions about the company’s future unless it can figure out a path forward with …

Related Topics:

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version